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Abstract
Medicinal plants always are part of folk medicine and are nowadays receiving worldwide attention for prophylaxis, manage-
ment, and treatment of several diseases, as an alternative to chemical drugs. The current work provided a comprehensive 
overview and analysis of the Astragalus and health relationship in literature. The analysis of their therapeutic potential is 
thus instrumental to understand their bioactivity. Among these, the flowering medicinal plant Astragalus membranaceus has 
raised interest due to several beneficial health effects. This perspective review discussed the botanical, geographical, histori-
cal, and the therapeutic properties of A. membranaceus, with a special focus on its health improving effects and medicinal 
applications both in vitro and in vivo.
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1 Introduction
Medicinal plants have long been used as a global strategy 
for the treatment of various diseases (Izzo et al. 2016). 
The International Union for the Conservation of Nature 
(IUCN) declared the use of 50,000–80,000 medicinal 
plants for medicinal purposes (Chen et al. 2016) in line 
with biodiversity and sustainability concept (Guarino and 
Pignatti 2010; Pignatti and Cipriani 2010; Pignatti 2013; 
Attore et al. 2018). Astragalus membranaceus (Fisch.) 
Bunge (syn. Astragalus propinquus Schischkin) is a plant 
from the Fabaceae (or Leguminosae) family, and a flow-
ering medicinal plant for which several beneficial effects 
have been identified, e.g., cardio; neuro; reno; and hepato-
protection, hypoglycemic, anti-osteoporosis, anti-fatigue, 
anti-inflammatory, anti-cancer, antioxidant, and immune 
system boosting. The geographical distribution of this 
plant has been reported at the edge of mountains and scat-
tered forests and grasslands, which grow predominantly in 
the inner Mongolia autonomous region and the northeast-
ern regions of Heilongjiang Province, China, as well as 
traditional medicine widely used the Radix Astragali, the 
dried root of A. membranaceus var. Commercial sales vol-
ume of Astragalus mongolicus is estimated at more than 
10 million tons per year (Zhang et al. 2019). The purpose 
of this review article is to investigate the botanical, geo-
graphical and historical characteristics of A. membrana-
ceus, in addition to gathering information about the main 
components and therapeutic purposes of the plant.
2  Astragalus and health: quantitative 
literature analysis
The current work provides a comprehensive overview and 
analysis of the Astragalus and health relationship in the lit-
erature. In January 2021, this search was conducted through 
the Scopus database to Astragalus and health publications. 
Bibliometric data were extracted from the Scopus online 
database using the search string: "Astragalus" and “Health”. 
Bibliographic data were recorded, such as the publication 
year, publication count, citation count, subject area, coun-
tries/territories, institutions, document type the “Analyze” 
and “Create Citation Report” functions of the Scopus web 
online platform have been used for the basic analyses. 
The “full records and cited references” were exported to 
VOSviewer software (version 1.6.16, VOSviewer software 
website) for further bibliometric analyses and additional 
processing.
The VOSviewer software (v.1.6.16, 2020) analyzes the 
terms/words used in the titles and abstracts of publications, 
by breaking down the paragraphs into words and phrases, 
linking them with the citation data of the publications, and 
visualizes the results in the form of a bubble map using a 
term map with default settings (Van Eck and Waltman 2009, 
2010, 2011; van Eck 2011; Waltman et al. 2010), Default 
parameters were used for the analyses and visualizations; 
particularly, the type of analysis was based on co-occur-
rence; as unit of analysis, all keywords were considered 
(author and index keywords), and the counting method was 
full counting. Create a map based on bibliographic data to 
create a co-authorship, keyword co-occurrence, citation, bib-
liographic coupling was selected. In a term map, the size of 
a bubble represents how frequently a term is mentioned in 
the articles—the frequency of appearance of a term (mul-
tiple mentions in one article were counted once). Two bub-
bles are positioned more closely to each other if the terms 
co-appeared more often in the analyzed publications. The 
color of a bubble reflects the average citations per publica-
tion (citations per publication, CPP).
To simplify the bubble map, words/terms that appeared 
in at least five publications have been analyzed and visual-
ized. As per the threshold chosen, the minimum number 
of occurrences of keyword was set up to 5. Of the 8502 
keywords, 678 meet the selected threshold and three of 
them were manually excluded. This search strategy identi-
fied publications that mentioned the relevant words or their 
derivatives in the title, abstract, or keywords. As a result, the 
following parameters were assessed: publication year, publi-
cation count, citation count, institution, country/territories, 
and document type.
The search returned 392 publications covering the time 
period from 1973 to 2021 that were collectively cited 10,270 
times, with an H-index of 55 and 26.19 CPP as an average.
A total of 675 terms have been derived from the quantita-
tive literature research on 392 publications and they are visu-
alized as a term map (Fig. 1). The top 10 recurring keywords 
are listed in Table 1. It is interesting to notice that among the 
top 10 recurring keywords appears as Astragalus membrana-
ceus, which shows as the research is mainly focused on the 
biological activities of this species.
Publications and citation trends of relationship between 
Astragalus and health research are reported in Fig. 2.
The type of documents related to the 392 publications 
with regard to Astragalus membranaceus retrieved was 
distributed as reported in Fig. 3. “Article” and “Review” 
account for the 65.8% and 25.8%, respectively, followed by 
“Conference paper” (3.6%) and “Book chapter” (2.3%).
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Figures 4 and 5 show, respectively, the most productive 
countries/territories and institutions with regard to Astra-
galus membranaceus. Regarding countries/territories, the 
most productive was China (n = 175, CPP = 20.41), followed 
by United States (n = 52, CPP = 27.23) and Taiwan (n = 30, 
CPP = 14.87).
The most productive institution with regard to Astragalus 
membranaceus was China Medical University Taichung 
(n = 17, CPP = 9.18). All Top 10 Institutions are in China 
and have at least or more 6 publications.
3  The botanical, geographical, 
and historical aspects of Astragalus 
(Astragalus membranaceus Bunge)
Astragalus membranaceus has been used as a valuable 
medicinal plant, especially in traditional Chinese medicine 
(TCM), also known as Huang Qi, in Chinese, Ogi, in Japa-
nese, Milk-Vetch, in English, and Gavan, in Persian (Shah-
rajabian et al. 2019). The geographical distribution of this 
genus, which is estimated to have 2000–000 different species, 
has been reported throughout the arid and temperate regions 
of the world (Li et al. 2014a), including about 120 species in 
Europe, 150 species in South American, 500 species in North 
American, and 1500 species in Asia. The main habitats of 
A. membranaceus are along sandy rivers, shrub edges, and 
sunny slopes. The main botanical characteristics defined for 
this perennial plant with 50–150 cm high, include a straight 
and long (up to 50 cm) cylindrical root, erect stems branched 
in the upper parts with small ovate-lanceolate or elliptical 
leaves with 7–30 mm long and 4–10 mm wide (13–31 lobu-
lar pieces), light yellow corolla, puberulous ovary, and black 
undercoated apex beaked and 2–2.5 cm ovate-oblong pods (Fu 
et al. 2014). This plant blooms from June to July and fruiting 
occurs from August to September. A. membranaceus dried 
root (Astragali Radix) has been consumed over 2000 years 
due to health-promoting effects. Traditional Chinese medicine 
recommended A. membranaceus to treat various gastrointes-
tinal disorders, including intestinal inflammation, chronic 
phlegmatic disorders, chronic diarrhea, and stomach ulcer 
(Bratkov et al. 2016).
Fig. 1  Term map for relationship of Astragalus and health research. 
Bubble size represents the number of publications. Bubble color rep-
resents the citations per publication (CPP). Two bubbles are closer to 
each other if the terms co-appeared more frequently. (Bibliometric 
data were extracted from the Scopus online database and elaborated 
by VOSviewer software)
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4  Main components of pharmaceutical 
character of Astragalus membranaceus
The main reported chemical constituents of A. membran-
aceus (Fig. 6) were triterpenes, polysaccharides, flavo-
noids, and saponins (Li et al. 2014a, b). The presence of 
compounds such as terpenoids and flavonoids that usually 
occur in free or glycosidic form is of relevant pharmaco-
logical interest due to the bioactivities attributed to these 
classes of compounds. The flavonoids include flavonols, 
flavones, flavanones, and isoflavonoids which have been 
described as having many types of bioactivities. Com-
pounds extracted with 75% methanol from different parts 
of Astragalus (roots, stems, leaves, petioles, and flow-
ers) were analyzed by UPLC-MS/MS technique, to eval-
uate flavonoids and triterpenoids distribution, together 
with 13 of their metabolites, showing that isoliquiriti-
genin, liquiritigenin, daidzein, and bioactive isoflavones 
accumulate in both roots and flowers (Liu et al. 2018). 
The content in the isoflavones, calycosin, and calycosin-
7-O-β-d-glucoside, was found to be the highest in the 
leaves and roots of A. membranaceus, as revealed by 
HPLC analysis (Kim et al. 2014). With calycosin content 
in leaf (145.56 μg/g DW) higher than in root (1.64 μg/g 
DW), while calycosin-7-O-β-d-glucoside content in root 
(4.88 μg/g DW) higher than leaf in (2.0 μg/g DW) (Kim 
et al. 2014). Kwon et al. (2013) analyzed the content in 
Astragalosides, known as the highly bioactive compound 
in A. membranaceus root, and reported that Astragalo-
sides are more concentrated in periderm and cortex than 
in xylem; and that unpeeled roots were richer in these 
compounds. Zhang et al. (2011) isolated 24 secondary 
metabolites (isoflavonoids, astragalasides, and benzoqui-
none) from A. membranaceus roots, and the (–)-methyl-
inissolin 3-O-β-d-glucosidewas detected for the first time 
in this study, and shown to possess potent anti-inflamma-
tory activity, evaluated by the inhibition of nitric oxide 
Table 1  The top 10 recurring terms on the relationship Astragalus 
and health research. (Bibliometric data were extracted from the Sco-
pus online database and elaborated by VOSviewer software)
Term Occurrence Total link 
strength
Human 229 6699
Unclassified drug 174 5255
Non-human 154 4329
Herbaceous agent 152 4661
humans 140 4384
Chinese medicine 112 3355
Astragalus membranaceus 112 3001
Controlled study 97 2883
Medicinal plant 87 2642
Drugs, Chinese herbal 87 2783
Fig. 2  Publication and cita-
tion trends of relationship 
between Astragalus and health 
research. (Bibliometric data 
were extracted from the Scopus 
online database)
Fig. 3  Distribution of documents with regard to Astragalus membran-
aceus by type. (Bibliometric data were extracted from the Scopus 
online database)
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(NO) released by lipopolysaccharide (LPS)-stimulated 
macrophages (RAW 264.7 cells). Ethanolic extract of 
Astragali Radix, analyzed by RP-HPLC, main content 
included triterpene saponins, namely astragaloside I–IV, 
isoflavonoids (formononetin and calycosin) which are the 
main bioactive compounds (Lee et al. 2017).
5  In vitro and in vivo therapeutic potentials 
of Astragalus (Astragalus membranaceus): 
an update shot
The evaluation of phytochemical composition can be con-
sidered as the first step for the determination of the benefi-
cial health properties of a plant, as it permits a preliminary 
approach on the assessment of chemical compound struc-
ture-related activities (Souto et al. 2019). Figure 7 shows 
the potential beneficial effects of this plant, e.g., neuro-
protection (Chan et al. 2009), renoprotection (Yin et al. 
2004; Wen et al. 2020), hepatoprotection (Ali et al. 2018), 
hypoglycemic (Kai et al. 2015), anti-osteoporosis (Koo 
et al. 2013), anti-fatigue (Berezutsky et al. 2019), anti-
inflammatory (He et al. 2012), immune system boosting 
(Lee et al. 2003), anti-cancer (Chen et al. 2019), antioxi-
dant (Lee et al. 2011), and cardioprotection (Zhang et al. 
2006).
Fig. 4  Most productive coun-
tries/territories with regard to 
Astragalus membranaceus. 
(Bibliometric data were 
extracted from the Scopus 
online database)
Fig. 5  Most productive institu-
tions with regard to Astragalus 
membranaceus. (Bibliometric 
data were extracted from the 
Scopus online database)
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5.1  Health‑promoting activities of Astragalus 
(Astragalus membranaceus) based on in vitro 
studies
Many health-promoting effects have been reported for A. 
membranaceus extracts. Table 2 shows the results of the 
main in vitro studies found in the literature. Zhang et al. 
(2020a, b) reported the main pharmacological effects of 
Astragaloside-IV, a major compound obtained with aque-
ous extraction, including neuroprotection, hepatoprotection, 
anti-diabetic anti-cancer activity, which were correlated with 
the antioxidant and anti-inflammatory activities exhibited 
by the modulation of various signaling pathways. These 
authors suggested the need for bioinformatics analysis to 
determine the effective Astragaloside-IV targets, for predic-
tion of drug–target interaction (Zhang et al. 2020a). The 
A. membranaceus dried root extract (70% ethanol extract) 
showed anti-diabetic effect by increasing glucose-stimulated 
insulin production and secretion from INS-1 cells, action 
attributed to the extract compounds nucleoside adenosine, 
formononetin, and calycosin-7-O-β-D-glucoside by path-
ways that result in the activation of peroxisome proliferator-
activated receptor-γ (PPAR-γ) and pancreatic and duode-
nal homeobox-1 (PDX-1) transcription factors, activation 
of phosphorylation of Akt, phosphatidylinositol 3-kinase 
(PI3K) pathway, through insulin receptor substrate-2 
(IRS-2) (Lee et al. 2019). Formononetin (7-hydroxy-4′-
methoxyisoflavone) was shown potential to treat diabetic 
retinopathy as it inhibited the vascular endothelial growth 
factor (VEGF) secretion, from a retinal cell model, through 
the HIF-1α/VEGF signaling pathway, compromising retinal 
neovascularization and reducing the expressions of PHD-2 
Fig. 6  Some main compounds 
present in A. membranaceus 
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(prolyl hydroxylase-2), HIF-1α (hypoxia-inducible factor 
1-alpha), and VEGF proteins (Wu et al. 2016). Anti-diabetic 
effect of Astragalus polysaccharide and Berberine, through 
improvement of insulin resistance by activation of several 
genes and signaling pathways in HepG2 cells that decrease 
reactive oxygen species (ROS) concentration and increasing 
the cell survival rate was also reported (Lin and Mao 2020). 
Astragalus polysaccharides resulted in a reduction in cellular 
apoptosis through the modulation of Bcl-2/Bax ratio and 
the prevention of pro-apoptotic protein expression in both 
intrinsic and extrinsic pathways (Sun et al. 2017).
In a study, the administration of Astragalus extract 
decreased the viability and induced the apoptosis of gastric 
cancer cell line via the AMPK pathway (Song et al. 2020). 
Zhang et al. (2018a) investigated that the ovarian cancer cell 
invasion and migration were inhibited through a decrease in 
the phosphorylation of ERK and the expression of MMP-
2/9 (Zhang et al. 2018a). Astragalus extracts induced apop-
tosis in non-small cell lung cancer cell line, by increasing 
cleaved caspase-8, -9 expression (Zhou et al. 2018). Others 
show that Astragalus polysaccharides induced cell-cycle 
arrest in 4T1 cells (Park and Park 2018). Jiang et al. (2019) 
reported the anti-cancer activity of formononetin as result-
ing from mechanisms involving halting metastasis, arresting 
cell cycle and inducing apoptosis, the  IC50 value of 1 µM 
for Formononetin against CNE2 (nasopharyngeal cell line) 
was reported. Wang and Ba (2015), analyzed the chemical 
composition of Astragali Radix ethanol extract using HPLC 
and NMR spectroscopy, and identified several compounds 
including (3R)-8,2’-dihydroxy-7,4’-dimethoxyisoflavan, 
7,2’-dihydroxy-3’,4’-dimethoxy-isoflavan-7,2’-dioxo-β-
d-glucoside, uridine, and astragaloside, which induced 
increase in the apoptosis rate of HepG2 cells, as evaluated 
by flow cytometry and MTT assay. Anticancer properties 
were also reported for the combination of apatinib [selec-
tive tyrosine kinase inhibitor of endothelial growth factor 
receptor-2 (VEGFR-2)] and Astragalus polysaccharide by 
enhancing cellular autophagy and blocking AKT pathway 
(Wu et al. 2018). The aerobic glycolysis metabolism of 
colorectal cancer cells (SW620 and HT-29 cell lines) was 
prevented by the administration of Astragalus saponins at 
the doses 50 µg/ml; the IC50 values of 35 and 46 µg/ml, at 
24 h, for HT-29 and SW620 cells, respectively, revealed anti-
cancer activity, confirmed by a significant reduction in the 
number of colony formation, after a treatment with 25 µg/
ml for 2 weeks (Guo et al. 2019). In an in vitro study, the 
pancreatic cancer cell growth was inhibited by the calycosin, 
extracted from A. membranaceus, via the induction of apop-
tosis and arrest of cell cycle (Zhang et al. 2020b). Calycosin 
exhibited anti-proliferative activity and inhibit cell migration 
in a human colorectal cancer cell model (HCT-116 cells), 
by mechanisms that involve up-regulation of ERβ and PTEN 
Fig. 7  Scheme of the Astragalus 
membranaceus Bunge therapeu-
tic properties































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































633Rendiconti Lincei. Scienze Fisiche e Naturali (2021) 32:625–642 
1 3
(phosphatase and tensin homolog deleted on chromosome 
ten) and downregulation of the micro-RNA miR-17, proba-
bly through regulation of miR-17/PTEN/Akt pathway (Chen 
et al. 2015).
Anti-myocardial H/R damage effect and regulation of the 
PI3K/Akt/HO-1 signaling pathway reported in a study by 
Yang et al. (2019).
In a study by Adesso et al. (2018), performed with rat 
intestinal crypt cell line (IEC-6 cells) co-exposed to the 
interferon-γ, lipopolysaccharide derived from E. coli (LPS) 
and A. membranaceus extract (5–100 µg/ml) showed that the 
extract of A. membranaceus root produced anti-inflamma-
tory effect that was reported by reducing the activation of 
nuclear factor-κB (NF-κB), the formation of nitrotyrosine, 
the expression of inducible nitric oxide synthase (iNOS) 
and of cycloxygenase-2 (COX-2), as well as the release 
of tumor necrosis factor-α (TNF-α). Adesso et al. (2018) 
also showed the antioxidant properties of A. membranaceus 
extract against hydrogen peroxide-induced oxidative stress 
by reducing ROS levels and by increasing expression of 
antioxidant cytoprotective factors, the activation of nuclear 
factor (erythroid-derived 2)-like 2 (Nrf2). Flavonoids of 
Astragalus extract exhibited anti-inflammatory and immu-
nomodulatory properties in LPS-induced RAW 264.7 cells 
by blocking the expression of nuclear NF-κBp65 and the 
phosphorylation of JNK and p38 in the NF-κB and MAPKs 
pathway, respectively, and by reducing the levels of COX-2 
and iNOS (Li et al. 2018). Total flavonoids extracted from 
Astragalus regulated the formation of NO, IFN-γ, IL-6, 
IL-1β, and TNF-α in RAW 264.7 macrophages, resulting 
in in vitro anti-inflammatory and immunomodulatory prop-
erties (Guo et al. 2016). The Astragalus saponins induced 
an anti-inflammatory effect by inhibiting LPS-induced 
NF-κB pathway resulting in decreased expression of iNOS 
(Wang et al., 2016). In a study using a standardized extract 
containing A. membranaceus and two other Korean herbs, 
KBH-JP-040 extract, caused anti-osteoarthritis potential by 
inhibiting JNK/p38 MAP-kinase pathway and preventing 
the production of NF-κB, IκBα, matrix metalloproteinase, 
and inflammatory cytokines (Rahman et al. 2018). Astraga-
loside-IV (100 µM) prevented myocardial remodeling and 
fibrosis in rat cardiomyocytes [H9C2(2–1)]] cell line through 
reduction in the activity levels of Sirt1, Bcl-2, miR-34a, as 
well as increasing superoxide dismutase activity and reduc-
tion of lipid peroxidation (Zhu et al. 2019). Astragalus poly-
saccharide could protect the cardiomyocyte cell line (H9c2) 
by reducing apoptosis induction that elevated cell viability, 
and by inhibiting the NF-κB and JNK pathways that sup-
pressed the production of the inflammatory cytokines, pos-
sible as a result of down-regulation of miR-127 expression 
(Ren et al. 2018).
Elevation in the immunosuppressive and the proliferative 
activities of umbilical cord-derived mesenchymal stem cells 
has been attributed to the reduction in the serum levels of 
IL-1β, IFN-γ, MCP-1, IL-6, and TNF-α (Chao et al. 2017).
The Bcl-2/Bax mRNA ratio, and GPx and SOD activi-
ties were increased, and the expression level of Bax mRNA 
was reduced in the interstitial cells of Leydig in rats (Jiang 
et al. 2015).
However, Kumar et al. (2018) reported that A. membrana-
ceus root extract altered the cytochrome P450 2B6 (CYP) 
activity, a reduction in CYP2B6 activity caused by ethyl 
acetate and ethanol extract was observed,  IC50 values of 29.7 
and 53.37 μg/ml, respectively. These results may indicate 
potential adverse drug interactions with CYPs, when A. 
membranaceus is co-administered with drugs metabolized 
by CYP2B6.
The antiviral activity of A. membranaceus against influ-
enza virus was shown in infected mouse Raw 264.7 cells by 
influencing the cell proliferating cycle, and by affecting the 
TLR3 signaling pathway, by reducing the malondialdehyde 
level, and increasing the superoxide dismutase level (Liang 
et al. 2019). Antibacterial activity of the aqueous Astragalus 
extract was demonstrated, as this could mildly inhibit bacte-
rial responsible by dysentery and diarrhea while not affect-
ing normal gut bacteria (Lai et al. 2018).
5.2  Health‑promoting activities of Astragalus 
(Astragalus membranaceus)  in animal models
Several health-promoting effects have been documented for 
A. membranaceus extracts in animal models. Table 3 shows 
the results of the main studies in animal models using A. 
membranaceus extracts. Wei et al. (2020) reported that the 
administration of 5 mg/kg/day of Astragaloside-IV in male 
Sprague–Dawley rats for 2 weeks treated cardiac fibrosis by 
declining the expression of collagen I, alpha-smooth muscle 
actin (α-SMA), and transient receptor potential melastatin-7 
(TRPM7) as well as by inhibiting the activity of TGF-β/
Smads pathway. Administration of Astragalus polysac-
charides in diabetic cardiomyopathy rat model (induced 
with streptozotocin, STZ) prevented the cardiomyocyte 
apoptosis due to down-regulation of PERK–ATF6–CHOP 
pathways of endoplasmic reticulum stress, which was also 
observed in vitro in high glucose-induced H9C2 cells (Sun 
et al. 2019). In a study by Cao et al. (2017), administra-
tion of 1.5 g/kg/day of Astragalus polysaccharide for 3 days 
improved the cardiomyocyte function in mice with doxoru-
bicin-induced heart failure, so that the induced heart failure 
by disturbing cardiomyocyte autophagic flux resulted in cell 
apoptosis that was reduced after Astragalus polysaccharide 
treatment through regulation of AMPK/mTOR pathway, 
decreasing doxorubicin-induced cardiotoxicity and restor-
ing normal autophagic flux. In another study, administration 
of astragaloside IV shows protective effect through elevation 
in the level of oxygen consumption ratio and reduction in the 
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anaerobic glycolysis in mice with heart failure (Dong et al. 
2017). Improvement of endothelial dysfunction, oxidation, 
matrix metalloproteinase (MMP)-2/9 function because of 
daily administration of Astragalus polysaccharides (128 mg/
kg), Astragalus total flavonoids (72 mg/kg), and Astragalus 
saponins (22 mg/kg), total extract of A. membranaceus 
(196 mg/kg) for 6 weeks in rats with hyperhomocysteinemia 
(HHcy) (Qiu et al. 2017). The cardioprotective activity of 
Astragaloside-IV was found following the down-regulation 
of miR-92a/-23a through the MAPK/ERK and PI3K/AKT 
signaling pathways (Gong et al. 2018). The administration 
of Astragalus polysaccharides (200 mg/kg b.w) elevated the 
antioxidant activity by declining apoptosis and preventing 
ROS-elicited oxidative damage (Awad et al. 2020). Chen 
et al. (2018) show that Astragalus extract inhibited oxida-
tive damage and ROS production, dropped progenitor cell 
apoptosis, and enhanced enzyme activities, SOD2 protein 
levels, the CSPCs’ cell proliferation, and CSPC abundance. 
Treatment with astragaloside IV inhibited type I collagen 
synthesis and isoprenaline-induced cardiac fibrosis prolif-
eration through dropping the activation of ROS-mediated 
MAPK signaling pathway (Dai et al. 2017). Yu et al. (2017) 
reported taking 2.5 mg/kg of astragaloside in rats for 4 
weeks prevented myocardial infarction-induced damage 
by upregulating Jagged1, Notch1, and HIF-1α expression. 
Others show that taking 80 mg/kg/day of Astragaloside-IV 
in rats reduced energy metabolic disturbance and pressure 
overload-induced hypertrophy via PGC-1α/PDK4/CPT-1 
pathway (Lu et al. 2016).
Administration of Astragalus in arthritis-induced rats 
for 4 weeks showed anti-arthritic properties attributed to 
the prevention of inflammatory mediators (Liu et al. 2017). 
The reduction in immune organ index, inflammatory cell 
infiltration, synovial hyperplasia and paw swelling, and the 
elevation of body weight have also been described (Maresca 
et al. 2017). The administration of 300 mg/kg per os of 
the hydroalcoholic extract of Astragali radix in a rat model 
showed anti-arthritic activity and relieved the pain by 
96% and 78% of complete Freund’s adjuvant and monoi-
odoacetate injection, respectively (Maresca et al. 2017). 
The daily co-administration of Salvia miltiorrhiza with A. 
membranaceus (10 ml/kg SM and 0.59 g/ml AM) in rats 
with LPS-induced acute lung injury for 3 consecutive days 
down-regulated the TLR4/IRAK/NF-κB signaling pathway 
and thus declined inflammatory cytokine release, vascular 
leakage and lung wet/dry weight ratio, and improved lung 
histopathological changes (Qin et al. 2018). In a study by 
Wang et al. (2019), treatment of mice with astragaloside 
IV (0.01 mg/g) by gavage for 6 days showed anti-inflam-
matory activity by inhibiting JNK, p38, and NF-κB sign-
aling pathways, resulting in reduced the consequences of 
LPS-induced endometritis like the levels of myeloperoxi-
dase (MPO), NO, TNF-α, and IL-1β. The administration 
of astragaloside at 40–80 mg/kg in rats for 10 weeks could 
significantly manage diabetic nephropathy by blocking the 
Wnt/β catenin signaling pathway, anti-epithelial–mesen-
chymal transition, anti-inflammatory, and anti-oxidative 
stress activities (Wang et al. 2020). The administration of 
Astragalus polysaccharide in male Sprague–Dawley rats 
enhanced bone marrow mesenchymal stem cell (BMSC) 
differentiation and proliferation by triggering Wnt/β-catenin 
and PI3K/AKT pathways through bone morphogenetic pro-
tein type 9 (BMP9) overexpression and miR-152 down-reg-
ulation (Li et al. 2019a, b). Daily administration of Astra-
galus polysaccharide, in ovariectomized rats, for 3 months, 
alleviated the osteoporosis caused by oxidative stress via 
the regulation of FoxO3a/Wnt2/β-catenin pathway (Ou 
et al. 2019). Astragaloside-IV extract administration to rats 
with ischemia–reperfusion injury showed neuroprotective 
activity, regulated the expression of apoptosis-related genes, 
improved the pathological brain damage and declined the 
cerebral infarction volume (Yin et al. 2020). Administration 
of Astragali Radix in mouse model of ischemia-induced 
brain damage for 3 days suppressed the expression levels of 
Aquaporin-4 (AQP-4) mRNA and protein, and that caused 
a reduction in water content, edema, and brain infarct size 
(Lim et al. 2019). Taking 10 g/day of Astragalus in mice 
inhibited the progression of renal fibrosis through the 
down-regulation of E-cadherin expression, the inhibition of 
TGFβ-R1, TGF-β1 and α-SMA expression, and the reduc-
tion in blood glucose levels (Yi et al. 2016). In a study by 
Li et al., anti-edema activity of Astragaloside-IV reported 
through the regulation of Matrix metalloproteinase-9 and 
aquaporin 4 (Li et al. 2013).
Rats treated with Astragalus polysaccharides exhibited an 
increase in the immunity function and a prevention of spleen 
deficiency by interfering with Toll-like receptor 4 (TLR4) 
and regulating inflammatory cytokines, respectively (Zhao 
et al. 2019). The Sheng-Nao-Kang decoction containing A. 
membranaceus extract exerted antithrombotic effect in rats 
by balancing the prostacyclin (PGI2) and thromboxane A2 
(TXA2) ratio (PGI2/TXA2), the anticoagulation activity 
and regulating the active substances produced by vascular 
endothelium (Dang et al. 2015). Li et al. (2019a, b) used 
an aqueous Astragalus extract, mainly composed of flavo-
noids, saponins, and polysaccharides, and then evaluated its 
immunomodulatory potential in mice at a dose of 1 g/kg 
twice a day for 18 days, and showed an improvement in the 
immune responses such as serum IgG and IgM levels, spleen 
lymphocyte subset, NK-cell activity, splenocyte prolifera-
tion, thymus and spleen parameters, peripheral white blood 
cell count, and body weight gain. Yu et al (2018) reported 
antitumor activity, following the administration of alcohol-
soluble A. membranaceus polysaccharide extract (100, 200, 
and 300 mg/kg), for 15 days in murine H22 heptoma cells, 
tumor cell apoptosis was induced due to an enhancement 
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of immune cell (NK cells, lymphocytes and macrophages) 
activities and serum levels of cytokines (IFN-γ, IL-2, and 
TNF-α). The administration of A. membranaceus decoction 
for a week prevented the intestinal mucosal damage due to 
the inhibition of inflammatory cytokine activity (Cui et al. 
2018). Astragaloside-IV modulated the host immune system 
through the excessive production of inflammatory mediators 
and the suppression of inflammation (Li et al. 2016b). Dia-
betic podocyte damage was decreased due to Panax notogin-
seng co-administrated with A. membranaceus via Nox4 and 
Bax down-regulation as well as Bcl-xl, α-dystroglycan, and 
nephrin up-regulation (Zhai et al. 2019).
In a mice model of infertility, treated with Astragalus root 
extract showed improvement within 56 days due to PPARα 
agonistic activity, so that the expression of ovarian PPARα 
mRNA and uterine was up-regulated for 1.5- and 2.5-fold, 
respectively (Orkhon et al. 2018). Co-administration of 
Laminaria japonica extract with A. membranaceus extract 
(200–400 mg/kg) in rats, for 6 weeks, attenuated the dys-
lipidemia and hypothyroidism caused by propylthiouracil 
(Mohibbullah et al. 2019). Kim et al. (2016) evaluated the 
effects of A. membranaceus (100, 500, 1000 mg/kg) for 
5 days a week for 5 weeks in mice, and reported an increase 
in the expression of cAMP response element modulator 
and activator of CREM in testis, as well as increased sperm 
value, motility, and count.
5.3  Health‑promoting activities of Astragalus 
(Astragalus membranaceus) in humans, 
with particular regards to clinical trials
There are several clinical trials evaluating the therapeutic 
effects of A. membranaceus extract. Table 4 summarizes 
the results of the main clinical trial studies. In the literature, 
there are some reports of anti-cancer activity attributed to the 
main compounds extracted from A. membranaceus, tested 
under clinical conditions, although only few studies report 
the improvement of the bioavailability of these compounds. 
Mao et al. (2020) reported a study in patients with myo-
cardial infarction who received Tongguan Capsules (TGC), 
containing a mixture of various herbs (A. membranaceus, 
Borneolum syntheticum, Salvia miltiorrhiza, and Grasshop-
per), at a dose of 4.5 g/day, for 6 months, in addition to the 
standard medication; in comparison to control group (only 
standard medication), the TGC-receiving patients shown 
significant reduction of left ventricular end-systolic vol-
ume index as well as lower incidence of the major adverse 
cardiovascular events, a decrease in myocardial markers of 
fibrosis and apoptosis, reduction in the circulating levels of 
inflammatory cytokines, indicating that the TGC treatment 
contributed to a more positive outcome.
Positive effect in children with growth retardation syn-
drome was reported, following the administration of HT042 
(NeuMed Inc. (Seoul, Korea) extract mixture (composed of: 
A. membranaceus roots, Eleutherococcus senticosus stems, 
and Phlomis umbrosa roots), twice a day for 24 weeks, who 
demonstrated to have increased serum levels of insulin-like 
growth factor binding protein-3 (IGFBP-3) and IGF-1, as 
well as height and weight gain was observed in all children 
(Lee et al. 2018). In a randomized study, the co-adminis-
tration of Astragalus polysaccharide with vinorelbine and 
cisplatin, in the patients with advanced non-small-cell lung 
cancer, improved quality of life and the side-effects of chem-
otherapy, such as appetite loss, pain, vomiting, nausea, and 
fatigue (Guo et al. 2012).
Immunostimulatory effect was reported as a result of 
double-blind study, in individuals subjected to treatment 
with 7.5 ml of an herbal tinctures consisting of Glycyrrhiza 
glabra, A. membranaceus, and Echinacea purpurea for 7 
consecutive days twice a day (via ingestion) that induced the 
proliferation and activation of human immune cells (Brush 
et al. 2006). Matkovic et al. (2010) reported the alleviation 
of seasonal allergic rhinitis symptoms, in patients treated 
with 80 mg of mineral complex, containing A. membran-
aceus root extract, for 6 weeks, resulting in positive sig-
nals such as decreased rhinorrhea intensity. Improvement 
of immune function was reported in a clinical trial, with 
patients with lupus nephritis received cyclophosphamide 
plus Astragalus (20 ml, intravenous drip infusion) daily for 
12 days that, after a month, showed an increase in the red 
blood cell count and in plasmatic albumin, and reduction 
in the urine protein content, infection rate, and active clini-
cal symptoms (P < 0.05), indicating positive effect (Su et al. 
2007).
6  Conclusions
Astragalus membranaceus is a widely used medicinal plant 
containing various natural bioactive compounds with thera-
peutic potential. For instance, Astragalus polysaccharides 
are monomeric components extracted from the plant that 
have been described for potential use in handling a range 
of diabetic complications (e.g., diabetic neuropathy, dia-
betic retinopathy, diabetic cardiomyopathy, diabetic foot, 
and infection). Among its compounds, Astragaloside-IV 
has been identified as one of the major constituents of its 
aqueous extract. It is a cycloartane-type triterpene glyco-
side chemical that has been described to have neuroprotec-
tive and hepatoprotective effects and can also be used as 
anti-cancer and anti-diabetic drug. Its antioxidant proper-
ties can also be exploited to improve neurotransmission and 
further neuroprotection. However, there is still a need for 
more comprehensive in vitro and in vivo studies, and clini-
cal trials to determine the effective correlation between the 
chemical composition of this plant and the molecular targets 
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that are responsible for the treatment of diseases that have 
been claimed, and also to draw definitive conclusions on 
the effects and consequences of prolonged administration 
of this plant. Human studies of a small number of health 
conditions indicate the need to use observational animal 
experiments for pharmacokinetic characterization. Health-
promoting effects of this plant suggest its added value for 
potential development of new nutraceuticals as a prophylac-
tic approach before a pharmacological treatment is needed, 
especially for people who are not eligible for conventional 
drug therapy. The quality of various chemical composi-
tions derived from A. membranaceus, in particular Astra-
gali Radix, is of great importance due to increasing demand 
of consumers. Moreover, there are needs to scientifically 
develop novel technologies to commercialize the plant 
products, such as pharmaceuticals, foods, health-promoting 
products, and cosmetics in integrated and multidisciplinary 
approach (Atanasov et al. 2021; Dwyer et al. 2021).
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